Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.00 | €51.20 | 50.581% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.53 | €54.21 | 48.398% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.26 | €55.00 | 5.243% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €48.90 | €57.50 | 17.587% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.37 | €61.56 | 16628.016% |
| LivaNova plc | 7 | 0 | 1 | 0 | €51.00 | €64.66 | 26.782% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €62.00 | €66.53 | 7.305% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €46.58 | €70.00 | 50.295% |
| Boston Scientific | 46 | 0 | 13 | 0 | €68.50 | €73.05 | 6.638% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €68.50 | €73.92 | 7.912% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €68.34 | €79.30 | 16.038% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €69.00 | €79.43 | 15.115% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €61.30 | €80.00 | 30.506% |
| Centene Corp. | 13 | 0 | 4 | 0 | €69.16 | €82.26 | 18.935% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| Hologic Inc. | 13 | 0 | 2 | 0 | €71.00 | €84.03 | 18.355% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.50 | €85.64 | 39.258% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €75.64 | €85.68 | 13.279% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €68.50 | €86.72 | 26.594% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €80.77 | €88.14 | 9.122% |
| Amedisys Inc. | 13 | 0 | 1 | 0 | €83.50 | €92.26 | 10.491% |